Novavax Initiates Phase 2 Portion of Phase 1/2 Clinical Trial of COVID-19 Vaccine
... its proprietary recombinant technology platform combines the power and speed of genetic engineering to efficiently produce highly immunogenic ... http://dlvr.it/RfHLMS
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.